(Q35581553)

9 August 2017

1 reference

title

Impact of psychostimulants on vesicular monoamine transporter function (English)

1 reference

9 August 2017

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

31 March 2024

author name string

Annette E. Fleckenstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14612158

31 March 2024

Glen R. Hanson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14612158

31 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

9 August 2017

31 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14612158

full work available at URL

31 March 2024

https://api.elsevier.com/content/article/PII:S0014299903023306?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

https://api.elsevier.com/content/article/PII:S0014299903023306?httpAccept=text/plain

31 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

European Journal of Pharmacology

31 March 2024

published in

1 reference

9 August 2017

volume

479

1 reference

9 August 2017

issue

1-3

1 reference

9 August 2017

page(s)

283-289

1 reference

Dopamine levels of two classes of vesicles are differentially depleted by amphetamine.

9 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Methamphetamine rapidly decreases vesicular dopamine uptake

31 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors

31 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

A single methamphetamine administration rapidly decreases vesicular dopamine uptake

31 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein

31 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Phencyclidine increases vesicular dopamine uptake

31 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse

31 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Expression cloning of a reserpine-sensitive vesicular monoamine transporter

31 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model

31 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity

31 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging

31 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice.

31 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons

31 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity

31 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Synaptic vesicular monoamine transporter expression: distribution and pharmacologic profile

31 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro

31 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity

31 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Regional heterogeneity of dopaminergic deficits in vervet monkey striatum and substantia nigra after methamphetamine exposure

31 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Enzymatic oxidation of dopamine: the role of prostaglandin H synthase

31 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations.

31 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

The long-term effects of multiple doses of methamphetamine on neostriatal trypthophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities

31 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport

31 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter

31 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis.

31 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography.

31 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Evidence for carrier-mediated efflux of dopamine from corpus striatum.

31 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Loss of striatal vesicular monoamine transporter protein (VMAT2) in human cocaine users

31 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons.

31 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei

31 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

31 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine

31 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain

31 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine

31 March 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors.

31 March 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits

31 March 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores.

31 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter.

31 March 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Radioligand binding and immunoautoradiographic evidence for a lack of toxicity to dopaminergic nerve terminals in human cocaine overdose victims.

31 March 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action.

31 March 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons.

31 March 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport

31 March 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity

31 March 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine

31 March 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine

31 March 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine

31 March 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes.

31 March 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

31 March 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users.

31 March 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

Long-term effects of chronic methamphetamine administration in rhesus monkeys

31 March 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.077

31 March 2024

Identifiers

1 reference

9 August 2017

1 reference